May 16, 2017

Express Scripts, Inc. et al v. Kaleo, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 17, 2017

    Express Scripts Says Kaléo Owes $14.5M In Naloxone Rebates

    Express Scripts Inc. on Tuesday accused Kaléo Inc. in Missouri federal court of unfairly increasing the price of its drug naloxone — which is used to save people overdosing on opioids — and then refusing to pay the pharmacy benefit manager nearly $14.5 million in corresponding rebates and fees.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS